My SRH My Choice: Wading through University Student’s Engagement in High Risk...iConferences
Prepared by Mary Njeri Wanjau, Pan Africa Christian University Kenya for International Conference on Public Health and Well-being 2019, 4-5 April, Negombo, Sri Lanka
Spatial heterogeneity and intervention effectsvaléry ridde
A presentation by Kate Zinszer (Université de Montréal) and Emmanuel Bonnet (Institut de recherche pour le développement).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
My SRH My Choice: Wading through University Student’s Engagement in High Risk...iConferences
Prepared by Mary Njeri Wanjau, Pan Africa Christian University Kenya for International Conference on Public Health and Well-being 2019, 4-5 April, Negombo, Sri Lanka
Spatial heterogeneity and intervention effectsvaléry ridde
A presentation by Kate Zinszer (Université de Montréal) and Emmanuel Bonnet (Institut de recherche pour le développement).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Bringing an ethics lens to the evaluation of a project on user fee exemptions...valéry ridde
Presentation by Matthew Hunt (McGill University).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Realizing the Promise of P4 Medicine by changing relationships presented by Catherine Lucey, MD, FACP; Interim Dean, The Ohio State University College of Medicine; Associate Vice President for HealthSciences Education, The Ohio State University
Perceived caregiver financial barriers and asthma outcomes in urban elementary school children
Minal R. Patel, MPH
Doctoral Student
Department of Health Behavior & Health Education
University of Michigan School of Public Health
American Thoracic Society International Conference , New Orleans, Louisiana
May 15, 2010
Center for Managing Chronic Disease
University of Michigan
What is implementation science and why should you careLisa Muldrew
This seminar will discuss the emerging field of implementation science with a focus on its application within clinical settings. Topics will include an overview of implementation science, how implementation science is positioned within the translation continuum, common conceptual models and analytic frameworks used in implementation science and a study example.
New York State Drug Court Program: The
participant will be able to: Demonstrate the efficacy of
patient navigation in order to improve maternal/child
health outcomes and parenting skills for the court
involved population.
Bringing an ethics lens to the evaluation of a project on user fee exemptions...valéry ridde
Presentation by Matthew Hunt (McGill University).
Global Health Workshop: Methods For Implementation Science in Global Health.
http://www.equitesante.org/implementation-science-methods-in-global-health/
Realizing the Promise of P4 Medicine by changing relationships presented by Catherine Lucey, MD, FACP; Interim Dean, The Ohio State University College of Medicine; Associate Vice President for HealthSciences Education, The Ohio State University
Perceived caregiver financial barriers and asthma outcomes in urban elementary school children
Minal R. Patel, MPH
Doctoral Student
Department of Health Behavior & Health Education
University of Michigan School of Public Health
American Thoracic Society International Conference , New Orleans, Louisiana
May 15, 2010
Center for Managing Chronic Disease
University of Michigan
What is implementation science and why should you careLisa Muldrew
This seminar will discuss the emerging field of implementation science with a focus on its application within clinical settings. Topics will include an overview of implementation science, how implementation science is positioned within the translation continuum, common conceptual models and analytic frameworks used in implementation science and a study example.
New York State Drug Court Program: The
participant will be able to: Demonstrate the efficacy of
patient navigation in order to improve maternal/child
health outcomes and parenting skills for the court
involved population.
Versão em português da apresentação de Jane Squires, uma das autoras do ASQ-3 (sigla para Ages and Stages Questionnaires), método de avaliação infantil desenvolvido nos Estados Unidos e utilizado em mais de 18 países, apresentado pela Secretaria de Assuntos Estratégicos (SAE) promoveu no dia 05 de dezembro de 2011.
Oluwayemisi Ishola: Contraceptive Use Autonomy, Decision and Dependence Level...GetItTogetherNG
This abstract was presented by The Challenge Initiative (TCI) at the 6th Nigeria Family Planning Conference which happened in Abuja from December 7 - 11, 2020.
School and community social influence programming for preventing tobacco and ...Health Evidence™
Health Evidence hosted a 90 minute webinar on substance use prevention and treatment interventions in children and adolescents, funded by the Canadian Centre on Substance Abuse. This webinar presented key messages and implications for practice.
This webinar focussed on interpreting the evidence in the following review, which synthesizes evidence related to social influence programming:
Skara, S. & Sussman, S. (2003). A review of 25 long-term adolescent tobacco and other drug use prevention program evaluations. Preventive Medicine (37) 451-474.
Misconceptions about Oral Contraceptive Pill Used Among Women at Primary Heal...iosrjce
IOSR Journal of Nursing and health Science is ambitious to disseminate information and experience in education, practice and investigation between medicine, nursing and all the sciences involved in health care. Nursing & Health Sciences focuses on the international exchange of knowledge in nursing and health sciences. The journal publishes peer-reviewed papers on original research, education and clinical practice.
By encouraging scholars from around the world to share their knowledge and expertise, the journal aims to provide the reader with a deeper understanding of the lived experience of nursing and health sciences and the opportunity to enrich their own area of practice. The journal publishes original papers, reviews, special and general articles, case management etc.
Managing missing values in routinely reported data: One approach from the Dem...MEASURE Evaluation
This Data for Impact webinar was held in December 2020. Access the recording and learn more at https://www.data4impactproject.org/resources/webinars/managing-missing-values-in-routinely-reported-data-one-approach-from-the-democratic-republic-of-the-congo/
This Data for Impact webinar took place October 29, 2020. Learn more at https://www.data4impactproject.org/resources/webinars/use-of-routine-data-for-economic-evaluations/
Data for Impact hosted a one-hour webinar sharing guidance for using routine data in evaluations. More: https://www.data4impactproject.org/resources/webinars/routine-data-use-in-evaluation-practical-guidance/
Lessons learned in using process tracing for evaluationMEASURE Evaluation
Access the recording for this Data for Impact (D4I) webinar at https://www.data4impactproject.org/lessons-learned-in-using-process-tracing-for-evaluation/
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
1. Contraceptive discontinuation in urban Honduras Janine Barden-O’Fallon, PhD Ilene Speizer, PhD University of North Carolina at Chapel Hill, USA 29 September 2009
2. Overview Results from a one-year follow-up study with reversible method users conducted in Honduras, 2006-2007 The study was funded by USAID and implemented by MEASURE Evaluation in collaboration with Programaspara el Desarollo de Infantes y Mujeres (PRODIM)
3. Contraceptive Discontinuation Common, though varies by country Most common during first 12 months of use Contributes to unmet need Can lead to unplanned pregnancy and unwanted births, resulting in negative public health outcomes
4. Objective To determine how multiple factors affect contraceptive discontinuation among users of temporary methods over a one-year period Demographic characteristics Fertility motivations Partner engagement Quality of FP services Experience of side effects Method characteristics
6. Data: Panel study collected in 2 rounds Baseline exit interviews with 800 women aged 15-44, attending a FP appointment in selected health facilities in which they received the injectable, IUD, or oral contraceptive pill Women were both new and continuing users There were no quotas by type of method Follow-up interviews completed with 671 (84%) 1 year later
7. Study sample at baseline (n=671) Young (94% under age 35) Educated (30% reached secondary or higher) Parity ≥ 1 Married/in union (89%) Urban residents (77%) Desire to space a birth 2+ years (50%) or no more children (34%)
11. Multivariate analysis: Cox proportional hazards models Model 1: Time until discontinuation of baseline method Model 2: Time until first episode of non-use of any method (Model 2) Covariates: demographic characteristics, fertility motivations and family engagement, experience of side effects, baseline service quality, and user status at baseline Stratified by baseline method
16. Discussion More than 4 out of 10 women discontinued the baseline method Living in rural areas may limit women’s ability to successfully switch methods Service quality had little effect on discontinuation Family and friends may support continuation
17. Thank you MEASURE Evaluation is funded by the U.S. Agency for International Development and is implemented by the Carolina Population Center at the University of North Carolina at Chapel Hill in partnership with Futures Group International, ICF Macro, John Snow, Inc., Management Sciences for Health, and Tulane University. The views expressed in this presentation do not necessarily reflect the views of USAID or the United States Government.
Editor's Notes
In-country collaborators- Javier Calix, Francisco Rodriguez, and Sadith Caceres, of PRODIM
A fairlylarge body of literatureon contraceptive discontinuation informs what we know already- that it is common (estimates vary by country; a recent summary of 18 DHS countries by Vadnais et al. found that 20-50% of users of reversible modern methods discontinued during the first 12 months of use). Often, discontinuation is due to reasons other than to become pregnant. In other research, Blanc & Curtis et al. found that discontinuation due to “reduced need” ranged between 7-20%. Findings such as these indicate that the majority of contraceptive discontinuation is “premature,” leaving fertile women without protection. Indeed, discontinuation has been shown to be related to unmet need, unintended pregnancy, and unwanted births.
Understanding the factors that contribute to discontinuation of family planning use is crucial to ensuring that women and couples can attain their long-term fertility goals. Weused an unpublished framework by Curtis and colleagues to identify a number of factors related to contraceptive discontinuation to include in the study. The objective was to…The factors which were included in the are:
The study was conducted in 4 urban areas of Honduras: Honduras is in the central region of Central America- it has a population of about 7.2 million; a TFR of 3.3, and a CPR of 65%. The most common method of contraception in the country is sterilization (33%), followed by injectables (21%), oral contraceptive pills (17%); and the IUD (10%).The cities included in the study are Tegucigalpa (capital, most populous), San Pedro Sula (large, industrial city in the north); and two regional cities, Santa Rosa de Copan and Gracias (in the Western, less developed region of the country)
The data for the study come from a panelof 800 women, aged 15-44 at baseline, who were recruited after attending a FP appointment in one of the selected health facilities. The selected health facilities included 7 Secretary of health clinics, one Secretary of Health hospital, and 5 clinics run by the Honduran Family Planning Association (ASHONPLAFA)- these types of facilities were the most common providers of female reversible methods in the four cities visited according to the most recent data. All women enrolled in the study were initiating or using injectables, IUD, or the contraceptive pill at the time of the baseline interview.About 200 women/city were enrolled between October-November 2006. The women were new to FP, new to a particular method, or what we call continuing (or returning) users.Baseline-Collected detailed information on contraceptive history, experience with side effects, couple dynamics & decision-making, motivations to avoid pregnancy, and service qualityAfter one year we conducted a follow-up interview with these women. We located and interviewed 671 women, (84%) of the original sample.Follow-up-Obtained detailed information on contraceptive use during the previous year in a month by month calendar, and included questions on the experience of side effects, pregnancies or births during the year, etc.
Read slide.There were no significant differences between the women interviewed at follow-up and the full sample of 800 women interviewed at baseline.
As you can see by this slide, the majority of women enrolled in the study at baselinewere using the injectable (72%); 21% of women were using the IUD and only 7% were using the Pill. We believe the low rate of pill users is reflective of the fact that women do not need to go to a clinic or get a prescription in order to obtain pills, and can purchase them at pharmacies.Herewomen are categorized into three groups based on contraceptive use status at the time of the baseline interview. About 52% were either getting a refill or having a consult about a method they were already using (“continuing users”). New adopters=new to FP (13%)New ‘switchers’=new to the method, reinitiating a method after a period of non-use (35%)
Life tables were used to construct discontinuation rates for women initiating a method at baseline. In this slide we see that among the 324 women initiating a method at baseline, 45% had stopped using their method by 12 months. Discontinuation during the first 12 months was most common for the injectable (at 50%) and Pill (at 44%- though it is a very small sample size).So discontinuation was common…
…But many women switched to another method without missing an episode of use (we define an episode of use as one month).This table shows us that discontinuation leading to at least one month of non-use was actually much lower, at 25% overall (compared to 45%). So, while 50% of women discontinued use of the injectable by 12 months, only 30% transitioned to a month or more of non-use.
Next to look at factors associated with contraceptive discontinuation in a multivariate analysis, we used Cox proportional hazards models. We ran two Models- the first, which will be presented in yellow, for the time until discontinuation of the baseline method; the second, which will be presented in lavender, for the time until the first episode of non-use of any method. Model 2, therefore, takes into consideration successful method switching.The covariates are those groups of factors that were outlined previously, including: demographics, fertility motivations, partner and family engagement, experience of side effects, baseline service quality, and user status at baseline.Baseline method type is used as a strata variable to allow for differences in the baseline hazard functions.
I’m going to present the covariate results by group to make the presentation easier to follow. What you see on this slide are the hazard ratios for demographic covariates that are significantly related to discontinuation (three asterisks=p<0.01; two asterisks=p<0.05; and the carot symbol=p<0.1; ). Note that a hazard ratio (HR) below 1.0 indicatesthat increases in the covariate reduce the hazard (or “likelihood”) of the indicated event, while a HR above 1.0 increase the likelihood of the event occurring. Again, Model 1, shown in yellow, are the hazard ratios for discontinuation of the baseline method while Model 2, in lavender, are the hazard ratios for experiencing an episode of non-use.Here we see that among demographic characteristics, being in the age group over 25, having a low parity and not being married or in union are associated with an increased likelihood of discontinuation, whereas only marital status and residence are related to an episode of non-use. While residing in an urban area is not significantly related to method discontinuation, it was found to be moderately related to a 26% reduction in the likelihood of experiencing an episode of non-use.
This slide has the covariates related to fertility motivations and family engagement.As would be expected, women who desired a child within 2 years had an increased likelihood of discontinuing the baseline method and of experiencing an episode of non-use as compared to women who wanted to wait more than 2 years, not have any more children, or who were undecided.Discussing side effects or health concerns with family members or friends in recent months was related to a 25% reduction in the likelihood of discontinuing and of experiencing an episode of non-use.There were no significant effects of discussing FP with the partner during the year or of feeling that the partner wanted more children than she, which were also included in the model.
This slide shows the covariates related to the experience ofside effects. Included in the model were heavy bleeding, weight gain, dizziness, headaches, amenorrhea, abdominal pain, and whether side effects had interfered with daily life or personal relationships.We see that a number of side effects are associated with an increased likelihood of method discontinuation, however this is not the case for transitioning to a period of non-use. Of women experiencing side effects, only women who experienced heavy bleeding had an increased risk of transitioning to an episode of non-use.
Finally, though this slide looks rather empty, it conveys some important information. Among a number of factors assessed for service quality at baseline, only four were included in the multivariate models, mainly because there was little variation in responses among many of the measures. The 4 included measures were: whether the woman had ever been informed by a health care provider about the side effects of her method; whether she was told at the baseline clinic appointment how to use the method effectively; whether she felt that all her questions had been answered by the provider; and whether the provider discussed 2 or more methods at her appointment. None of these factors were shown to be associated with the likelihood of discontinuation; however, women who felt that their provider had answered all their questions were 24% less likely to transition to a period of non-use than women who did not feel this way. (at p<0.1)